Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
Kyriazopoulou E, Liaskou-Antoniou L, Adamis G, Panagaki A, Melachroinopoulos N, Drakou E, Marousis K, Chrysos G, Spyrou A, Alexiou N, Symbardi S, Alexiou Z, Lagou S, Kolonia V, Gkavogianni T, Kyprianou M, Anagnostopoulos I, Poulakou G, Lada M, Makina A, Roulia E, Koupetori M, Apostolopoulos V, Petrou D, Nitsotolis T, Antoniadou A, Giamarellos-Bourboulis EJ. Kyriazopoulou E, et al. Among authors: petrou d. Am J Respir Crit Care Med. 2021 Jan 15;203(2):202-210. doi: 10.1164/rccm.202004-1201OC. Am J Respir Crit Care Med. 2021. PMID: 32757963 Free PMC article. Clinical Trial.
Immune responses of patients on maintenance hemodialysis after infection by SARS-CoV-2: a prospective observational cohort study.
Bacharaki D, Karagiannis M, Giannakopoulos P, Papachristou E, Divanis D, Sardeli A, Petrou D, Nikolopoulos P, Bratsiakou A, Zoi V, Piliouras N, Damoraki G, Liakopoulos V, Goumenos D, Giamarellos-Bourboulis EJ. Bacharaki D, et al. Among authors: petrou d. BMC Infect Dis. 2023 Sep 6;23(1):581. doi: 10.1186/s12879-023-08569-2. BMC Infect Dis. 2023. PMID: 37674148 Free PMC article.
IgA Nephropathy: Current Treatment and New Insights.
Petrou D, Kalogeropoulos P, Liapis G, Lionaki S. Petrou D, et al. Antibodies (Basel). 2023 Jun 19;12(2):40. doi: 10.3390/antib12020040. Antibodies (Basel). 2023. PMID: 37366657 Free PMC article. Review.
Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational trial.
Athanassiou P, Katsimbri P, Bounas A, Gazi S, Sarikoudis T, Syrigou V, Boumpas D; EMBRACE Study Group. Athanassiou P, et al. Clin Rheumatol. 2024 May;43(5):1469-1478. doi: 10.1007/s10067-024-06916-5. Epub 2024 Mar 12. Clin Rheumatol. 2024. PMID: 38472527 Free PMC article.
Correction: Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).
Hadjigeorgiou G, Dardiotis E, Tsivgoulis G, Doskas T, Petrou D, Makris N, Vlaikidis N, Thomaidis T, Kyritsis A, Fakas N, Treska X, Karageorgiou C, Sotirli S, Giannoulis C, Papadimitriou D, Mylonas I, Kouremenos E, Vlachos GS, Georgiopoulos D, Mademtzoglou D, Vikelis M, Zintzaras E. Hadjigeorgiou G, et al. Among authors: petrou d. PLoS One. 2015 Oct 6;10(10):e0140308. doi: 10.1371/journal.pone.0140308. eCollection 2015. PLoS One. 2015. PMID: 26440275 Free PMC article. No abstract available.
Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).
Hadjigeorgiou G, Dardiotis E, Tsivgoulis G, Doskas T, Petrou D, Makris N, Vlaikidis N, Thomaidis T, Kyritsis A, Fakas N, Treska X, Karageorgiou C, Sotirli S, Giannoulis C, Papadimitriou D, Mylonas I, Kouremenos E, Vlachos G, Georgiopoulos D, Mademtzoglou D, Vikelis M, Zintzaras E. Hadjigeorgiou G, et al. Among authors: petrou d. PLoS One. 2014 Nov 24;9(11):e113933. doi: 10.1371/journal.pone.0113933. eCollection 2014. PLoS One. 2014. PMID: 25419842 Free PMC article.
Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial.
Karanikolas GN, Koukli EM, Katsalira A, Arida A, Petrou D, Komninou E, Fragiadaki K, Zacharioudaki A, Lasithiotakis I, Giavri E, Vaiopoulos G, Sfikakis PP. Karanikolas GN, et al. Among authors: petrou d. J Rheumatol. 2011 Nov;38(11):2466-74. doi: 10.3899/jrheum.110242. Epub 2011 Sep 1. J Rheumatol. 2011. PMID: 21885499 Clinical Trial.